- Home
- NATR vs INZY Comparison
NATR vs INZY Comparison
Compare NATR & INZY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NATR
- INZY
- Stock Information
- Founded
- NATR 1972
- INZY 2015
- Country
- NATR United States
- INZY United States
- Employees
- NATR N/A
- INZY N/A
- Industry
- NATR Biotechnology: Pharmaceutical Preparations
- INZY Biotechnology: Pharmaceutical Preparations
- Sector
- NATR Health Care
- INZY Health Care
- Exchange
- NATR Nasdaq
- INZY Nasdaq
- Market Cap
- NATR 269.6M
- INZY 256.3M
- IPO Year
- NATR N/A
- INZY 2020
- Fundamental
- Price
- NATR $15.59
- INZY N/A
- Analyst Decision
- NATR Strong Buy
- INZY Buy
- Analyst Count
- NATR 2
- INZY 9
- Target Price
- NATR $18.50
- INZY $15.22
- AVG Volume (30 Days)
- NATR 116.4K
- INZY 989.2K
- Earning Date
- NATR 08-07-2025
- INZY 08-05-2025
- Dividend Yield
- NATR N/A
- INZY N/A
- EPS Growth
- NATR N/A
- INZY N/A
- EPS
- NATR 0.53
- INZY N/A
- Revenue
- NATR $456,619,000.00
- INZY N/A
- Revenue This Year
- NATR $3.08
- INZY N/A
- Revenue Next Year
- NATR $2.41
- INZY N/A
- P/E Ratio
- NATR $29.49
- INZY N/A
- Revenue Growth
- NATR 2.00
- INZY N/A
- 52 Week Low
- NATR $10.81
- INZY $0.72
- 52 Week High
- NATR $18.06
- INZY $6.24
- Technical
- Relative Strength Index (RSI)
- NATR 61.56
- INZY 82.67
- Support Level
- NATR $13.39
- INZY $3.94
- Resistance Level
- NATR $14.92
- INZY $3.97
- Average True Range (ATR)
- NATR 0.52
- INZY 0.01
- MACD
- NATR 0.02
- INZY -0.08
- Stochastic Oscillator
- NATR 94.50
- INZY 100.00
About NATR Nature's Sunshine Products Inc.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
About INZY Inozyme Pharma Inc.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.